NutraIngredients has published a feature on a major milestone for KÄÄPÄ Biotech. The article covers the recent approval by the European Food Safety Authority (EFSA) of our proprietary NordReleaseTM extraction process — a significant recognition that confirms our mushroom extract powders are considered non-novel foods under EU regulations.
This EFSA approval is another step by KÄÄPÄ Biotech towards bringing its customers the absolute best quality functional mushroom products, having achieved FSSC 22000 approval in early 2023. The FSSC 22000 scheme provides a certification model used in the food manufacturing industry and the related supply chain to ensure food safety standards and processes.
“We feel this landmark EFSA decision has opened the path for high quality and effective EU-produced functional mushroom extracts for both our existing customers who are growing and new partners,” said Eric Puro, CEO of KÄÄPÄ Biotech to NutraIngredients.
Read the full article here.